Latest Expansion News

Eminence Minerals has expanded into a 1,508 km² Côte d’Ivoire gold portfolio while advancing rare earths exploration in Brazil and awaiting a key Hamersley court decision. The company ended September with A$2.869 million in cash, equivalent to 2.31 quarters of funding at the reported burn rate.

Duxton Farms returned to positive operating cash flow in the September quarter, but its balance sheet remains stretched with a $13.98 million net overdraft and $103.25 million of drawn financing. A secured convertible note raise and a delayed asset sale are now central to the company’s funding position.

Metal Powder Works has secured its first multi-year order, lifting backlog to approximately A$1.3 million and bringing forward its 800-tonne annual capacity target. The commercial progress comes with a sharper funding question, as quarterly operating cash outflow reached A$3.3 million against A$6.9 million of cash.

OMG Group has confirmed its first positive quarterly EBITDA, with Q1 FY27 sales rising 59% to approximately $1.92 million and gross profit growing faster than revenue. The result marks an earnings milestone, but operating cash flow remained negative as the company invested heavily in inventory and supplier deposits.

Sultan Resources has ended the September quarter with $1.652 million in cash as it builds a copper-gold exploration portfolio spanning Namibia and New South Wales. The company’s most advanced near-term work remains contingent on a licence grant, geophysical reviews and shareholder approvals.

HITIQ has expanded its military research ambitions and added fresh funding during the September quarter, but the company ended the period with $658,242 in cash and estimated funding for only one quarter. Its US collaboration remains non-binding, leaving financing and commercial execution as the immediate tests.

Noble Helium has completed the groundwork for its Kinambo drilling campaign in Tanzania, but the program remains paused after wireline contractor SLB was delayed on another project. The company ended September with A$3.905 million in cash, equivalent to an estimated 1.61 quarters of funding at current outgoings, while expanding into Western Australia through the completed Earth Source Hydrogen acquisition.

Catalyst Metals has cut FY27 production guidance to 90,000-105,000 ounces after deferring Trident and Old Highway output to FY28. The downgrade comes despite a stronger balance sheet, a 2Moz Plutonic Reserve base and A$40 million of quarterly cash generation.

Decidr AI Industries reported a sharp quarterly fall in its invoicing-based AER, even as customer receipts reached a record and Sugarwork’s qualified pipeline expanded. The company is relying on A$11 million of annualised cost reductions and upcoming product launches to extend its runway and convert enterprise interest into recurring revenue.

OncoSil Medical enters FY27 with FDA approval for its cancer device, rising quarterly revenue and fresh institutional funding, but its U.S. opportunity still depends on reimbursement and a tightly controlled initial rollout. Cash rose to A$8.7 million after the capital raise, while operating cash use remained substantial.

Bio-Gene Technology has moved closer to two commercialisation milestones, with Qcide product work progressing in Japan and a first Flavocide regulatory submission targeted for Q2 2027. The company ended September with A$2.103 million in cash, equivalent to an estimated 2.18 quarters of funding at the quarter’s operating cash rate.

Way2VAT is betting that its new Way2Invoice platform, Coupa distribution and Go-Global partnership can convert product momentum into recurring revenue, while a 15% cost reduction begins to address ongoing cash burn. Quarterly revenue was broadly flat at A$1.90 million, with A$3.05 million in cash and A$5.20 million of debt drawn at quarter end.